AI made execution free. Knowing first is the whole game now.
The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.
Trusted by
OracleSnowflakeCloudflareLinkedInGoogleSalesforce
★★★★★4.8/5 on G2· Since 2015
Navigator Medicines announced it raised $10 Million in an initial filing from an offering of $40 Million
PRIVATESep 25, 2026
Amount Raised
$10 Million
Round Type
Venture
Scotch PlainsBiotechnologyHealth CareTherapeutics
Company Information
Company
Navigator Medicines
Location
Scotch Plains, New Jersey, United States
About
Navigator Medicines is a biotech company leading the advancement of biologics for targeted immune regulation & restoration. Founded in 2024 as a subsidiary of Sera Medicines, the Company is committed to developing new therapies for patients living with complex, heterogeneous autoimmune diseases. NAV-240, their clinical-stage bispecific antibody, targets OX40L and TNFα to address critical inflammatory diseases. The company is focused on innovation that enhances patient care.
Fundz sees it the moment Navigator Medicines raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.